Brief: Median Technologies : Promising Results On The Use Of The IBiopsy® Platform

Median Technologies SA

08/09/2020 16:56

Sept 8 (Reuters) - MEDIAN TECHNOLOGIES SA  ALMDT.PA :
    * PROMISING RESULTS ON THE USE OF THE IBIOPSY® PLATFORM IN
THE
CONTEXT OF MEASURING THE ANTI-TUMOR IMMUNE RESPONSE
    * ESTABLISHMENT OF A BIOMARKER DERIVED FROM CT IMAGING TO
CHARACTERIZE THE TUMOR MICROENVIRONMENT
    * A BIOMARKER FOR IDENTIFYING PATIENTS RESPONDING TO
TREATMENT
BASED ON ANTI-TUMOR IMMUNITY OF CD8+ CELLS

Source text for Eikon:  ID:nBw86fgRqa 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))